Relevant links

Heggebø LC, Johannessen TA, Magelssen H, Sprauten M, Blakstad H, Brekke J, Goplen D, Marienhagen K, Solheim TS, Bjorland L, Brandal P (2026)
Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy
Clin Transl Radiat Oncol, 58, 101140
DOI 10.1016/j.ctro.2026.101140, PubMed 41798870

Mendoza Mireles EE, Blakstad H, Server A, Leske H, Skaga E, Aarhus M, Brandal P, Helseth E, Nayak L, Rønning PA, Vik-Mo EO (2026)
Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study
J Neurooncol, 177 (1)
DOI 10.1007/s11060-026-05481-y, PubMed 41733819

Slørdahl KS, Puco K, Falk RS, Dyvik I, Brabrand S, Niehusmann P, Steinskog ESS, Blix ES, Flobak Å, Oppedal IA, Meltzer S, Torkildsen CF, Blakstad H, Lindemann K, Smeland S, Amundsen A, Taskén K, Helland Å, InPred Consortium (2026)
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial
Acta Oncol, 65, 90-96
DOI 10.2340/1651-226X.2026.45086, PubMed 41664938